A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer

Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)

NCT03053297 ·Status: TERMINATED

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

NCT00094094 ·Status: COMPLETED ·Phase: PHASE2

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

NCT00020202 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

NCT00862134 ·Status: TERMINATED ·Phase: PHASE2

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

NCT02963610 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT04222972 ·Status: TERMINATED ·Phase: PHASE3

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

NCT00801801 ·Status: TERMINATED ·Phase: PHASE2

Analysis of Biopsy Specimens to Study Responses to PD-1 or PD-L1 Therapies

NCT03877250 ·Status: WITHDRAWN

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

NCT01159327 ·Status: TERMINATED ·Phase: PHASE2

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957 ·Status: COMPLETED ·Phase: PHASE2

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00086333 ·Status: COMPLETED ·Phase: PHASE2

Non-small Cell Lung Cancer Study US75 (Z-PACT)

NCT00086268 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

NCT01159964 ·Status: TERMINATED ·Phase: PHASE1

Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

NCT00420732 ·Status: TERMINATED ·Phase: PHASE2

RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil

NCT06491862 ·Status: RECRUITING

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

NCT00050830 ·Status: COMPLETED ·Phase: PHASE2

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT03845296 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

NCT02590965 ·Status: COMPLETED ·Phase: PHASE2

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

NCT02299141 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

NCT02318368 ·Status: TERMINATED ·Phase: PHASE2

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

NCT05275868 ·Status: TERMINATED ·Phase: PHASE1

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00923312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer

NCT02963090 ·Status: TERMINATED ·Phase: PHASE2

A Study Of PF-06664178 In Patients With Advanced Solid Tumors

NCT02122146 ·Status: TERMINATED ·Phase: PHASE1

Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer

NCT00864266 ·Status: COMPLETED ·Phase: NA